These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4275059)

  • 1. [Biotransformation of carcinogenic dialkylnitrosamines. Further urinary metabolites of di-n-butyl- and di-n-pentyl-nitrosamine (author's transl)].
    Blattmann L; Preussmann R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):75-8. PubMed ID: 4275059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure of rat urinary metabolites of carcinogenic dialkylnitrosamines (author's transl)].
    Blattmann L; Preussmann R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973; 79(1):3-5. PubMed ID: 4281165
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structure of rat urinary metabolites of the carcinogen methyl-n-butyl-nitrosamine (author's transl)].
    Blattmann L; Joswig N; Preussmann R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):71-3. PubMed ID: 4275058
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic fate of asymmetric N,N-dialkylnitrosamines having butyl group in the rat.
    Suzuki E; Okada M
    Gan; 1981 Dec; 72(6):910-20. PubMed ID: 7341340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M; Suzuki E; Hashimoto Y
    Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct alkyl chain cleavage after C-hydroxylation of dialkylnitrosamines in rats. A new pathway of the oxidative biotransformation.
    Blattmann L
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977; 88(3):315-22. PubMed ID: 140546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of N,N-dibutylnitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial formation of beta-oxopropyl metabolites from bladder carcinogenic omega-carboxyalkylnitrosamines.
    Janzowski C; Landsiedel R; Gölzer P; Eisenbrand G
    Chem Biol Interact; 1994 Jan; 90(1):23-33. PubMed ID: 8131217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of asymmetric N-dialkylnitrosamines in rat tissues derived from the ventral entoderm.
    Ludeke B; Meier T; Kleihues P
    IARC Sci Publ; 1991; (105):286-93. PubMed ID: 1855867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of N-butyl-N-(3-formylpropyl)nitrosamine to N-butyl-N-(3-carboxypropyl)nitrosamine in rat liver and inhibition by disulfiram.
    Irving CC
    Carcinogenesis; 1988 Nov; 9(11):2109-12. PubMed ID: 3180345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder.
    Suzuki E; Aoki J; Okada M
    Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Apr; 72(2):254-8. PubMed ID: 7286549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. Selective induction of urinary bladder tumours in the rat.
    Okada M; Ishidate M
    Xenobiotica; 1977; 7(1-2):11-24. PubMed ID: 191997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental model for evaluating animal exposure to endogenous N-nitrosodi-n-butylamine by measuring its urinary metabolites N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-butyl-N-(3-carboxypropyl)nitrosamine.
    Airoldi L; Spagone C; Macri A; Fanelli R
    IARC Sci Publ; 1984; (57):237-40. PubMed ID: 6533013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the carcinogenetic action of N-nitroso compounds. 7th communication: methyl-, trideuteromethyl-, ethyl-, n-propyl-, n-butyl-, acetoxymethyl-nitrosamine, and methyl-butyroxymethyl-nitrosamine (author's transl)].
    Wiessler M; Habs M; Schmähl D
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1978; 91(3):317-22. PubMed ID: 151397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okada M; Suzuki E; Iiyoshi M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3909-13. PubMed ID: 747858
    [No Abstract]   [Full Text] [Related]  

  • 20. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.